{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-9202"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-9202","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"The Relationship between Continuous Glucose Monitor (CGM) Derived Metrics and Indices of Glycemic Control","abstract":"Introduction: Both hypoglycemia (low blood glucose) and hyperglycemia (high blood glucose) are common among individuals with type 1 diabetes and are associated with severe medical complications, therefore it is essential that health care providers are able to accurately measure glycemic control. Measures derived from continuous glucose monitoring (CGM) may provide more accurate measurements of glycemia than the commonly used HbA1c blood test. Methods: Data from the Juvenile Diabetes Research Foundation (JDRF) clinical trial to assess the efficacy of continuous glucose monitoring was used to estimate the ability of CGM composite scores to predict time in range, time in hyperglycemia and time in hypoglycemia. Spearman partial correlation coefficients were calculated between composite measures and thresholds of glycemia. Results: HbA1c showed week correlations with time below 54 mg/dL (R = -0.05) and time below 70 mg/dL (R = -0.21). HbA1c was moderately correlated with time in range (R = -0.62), however, most other CGM derived metrics had stronger correlations. HbA1c was also moderately correlated with time above 180 mg/dL (R = 0.68) and time above 250 mg/dL (R = 0.64), however several CGM derived composite scores including the J-index, GRADE, the Q-score, GMI, CGP, and PGS all had stronger correlations with time in hyperglycemia (Table 3). Conclusions: HbA1c is a poor predictor of time in hypoglycemia and moderately correlated with time in hyperglycemia. Several composite metrics had stronger correlations with both hypo and hyperglycemia than HbA1c and were better predictors of meeting clinical targets.","abstract_html":"Introduction: Both hypoglycemia (low blood glucose) and hyperglycemia (high blood glucose) are common among individuals with type 1 diabetes and are associated with severe medical complications, therefore it is essential that health care providers are able to accurately measure glycemic control. Measures derived from continuous glucose monitoring (CGM) may provide more accurate measurements of glycemia than the commonly used HbA1c blood test. Methods: Data from the Juvenile Diabetes Research Foundation (JDRF) clinical trial to assess the efficacy of continuous glucose monitoring was used to estimate the ability of CGM composite scores to predict time in range, time in hyperglycemia and time in hypoglycemia. Spearman partial correlation coefficients were calculated between composite measures and thresholds of glycemia. Results: HbA1c showed week correlations with time below 54 mg/dL (R = -0.05) and time below 70 mg/dL (R = -0.21). HbA1c was moderately correlated with time in range (R = -0.62), however, most other CGM derived metrics had stronger correlations. HbA1c was also moderately correlated with time above 180 mg/dL (R = 0.68) and time above 250 mg/dL (R = 0.64), however several CGM derived composite scores including the J-index, GRADE, the Q-score, GMI, CGP, and PGS all had stronger correlations with time in hyperglycemia (Table 3). Conclusions: HbA1c is a poor predictor of time in hypoglycemia and moderately correlated with time in hyperglycemia. Several composite metrics had stronger correlations with both hypo and hyperglycemia than HbA1c and were better predictors of meeting clinical targets.","abstract_has_math":false,"creators":["Bailey, Ryan"],"institution":"University of South Florida","degree_name":"Master of Science (M.S.)","degree_level":"Thesis","degree_discipline":"Public Health","degree_department":null,"school":null,"contributors":["Janice Zgibor, Ph.D.","Amy Alman, Ph.D.","Skai Schwartz, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019-10-22T07:00:00Z","date_published":"2019-10-22T07:00:00Z","updated_at":"2026-11-19T08:44:36Z","subjects":["Diabetes","HbA1c","Hyperglycemia","Hypoglycemia","Epidemiology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/8005","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/8005","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-9202","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Janice Zgibor, Ph.D.","Amy Alman, Ph.D.","Skai Schwartz, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Bailey, Ryan"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2019-10-22T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Public Health"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis","M.S."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Diabetes","HbA1c","Hyperglycemia","Hypoglycemia","Epidemiology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/8005"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Introduction: Both hypoglycemia (low blood glucose) and hyperglycemia (high blood glucose) are common among individuals with type 1 diabetes and are associated with severe medical complications, therefore it is essential that health care providers are able to accurately measure glycemic control. Measures derived from continuous glucose monitoring (CGM) may provide more accurate measurements of glycemia than the commonly used HbA1c blood test. Methods: Data from the Juvenile Diabetes Research Foundation (JDRF) clinical trial to assess the efficacy of continuous glucose monitoring was used to estimate the ability of CGM composite scores to predict time in range, time in hyperglycemia and time in hypoglycemia. Spearman partial correlation coefficients were calculated between composite measures and thresholds of glycemia. Results: HbA1c showed week correlations with time below 54 mg/dL (R = -0.05) and time below 70 mg/dL (R = -0.21). HbA1c was moderately correlated with time in range (R = -0.62), however, most other CGM derived metrics had stronger correlations. HbA1c was also moderately correlated with time above 180 mg/dL (R = 0.68) and time above 250 mg/dL (R = 0.64), however several CGM derived composite scores including the J-index, GRADE, the Q-score, GMI, CGP, and PGS all had stronger correlations with time in hyperglycemia (Table 3). Conclusions: HbA1c is a poor predictor of time in hypoglycemia and moderately correlated with time in hyperglycemia. Several composite metrics had stronger correlations with both hypo and hyperglycemia than HbA1c and were better predictors of meeting clinical targets."]},{"key":"dc:title","label":"Title","values":["The Relationship between Continuous Glucose Monitor (CGM) Derived Metrics and Indices of Glycemic Control"]}]}],"canonical_facts":{"dc:contributor":["Janice Zgibor, Ph.D.","Amy Alman, Ph.D.","Skai Schwartz, Ph.D."],"dc:creator":["Bailey, Ryan"],"dc:date":["2019-10-22T07:00:00Z"],"dc:description":["Introduction: Both hypoglycemia (low blood glucose) and hyperglycemia (high blood glucose) are common among individuals with type 1 diabetes and are associated with severe medical complications, therefore it is essential that health care providers are able to accurately measure glycemic control. Measures derived from continuous glucose monitoring (CGM) may provide more accurate measurements of glycemia than the commonly used HbA1c blood test. Methods: Data from the Juvenile Diabetes Research Foundation (JDRF) clinical trial to assess the efficacy of continuous glucose monitoring was used to estimate the ability of CGM composite scores to predict time in range, time in hyperglycemia and time in hypoglycemia. Spearman partial correlation coefficients were calculated between composite measures and thresholds of glycemia. Results: HbA1c showed week correlations with time below 54 mg/dL (R = -0.05) and time below 70 mg/dL (R = -0.21). HbA1c was moderately correlated with time in range (R = -0.62), however, most other CGM derived metrics had stronger correlations. HbA1c was also moderately correlated with time above 180 mg/dL (R = 0.68) and time above 250 mg/dL (R = 0.64), however several CGM derived composite scores including the J-index, GRADE, the Q-score, GMI, CGP, and PGS all had stronger correlations with time in hyperglycemia (Table 3). Conclusions: HbA1c is a poor predictor of time in hypoglycemia and moderately correlated with time in hyperglycemia. Several composite metrics had stronger correlations with both hypo and hyperglycemia than HbA1c and were better predictors of meeting clinical targets."],"dc:identifier":["https://digitalcommons.usf.edu/etd/8005"],"dc:subject":["Diabetes","HbA1c","Hyperglycemia","Hypoglycemia","Epidemiology"],"dc:title":["The Relationship between Continuous Glucose Monitor (CGM) Derived Metrics and Indices of Glycemic Control"],"thesis:degree_discipline":["Public Health"],"thesis:degree_level":["Thesis","M.S."],"thesis:degree_name":["Master of Science (M.S.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:44:36Z"}